← Back to headlines
Warnings Against Off-Label Use of Diabetes Drug Mounjaro for Diet
Japanese medical societies and pharmaceutical companies are issuing warnings against the use of the Type 2 diabetes drug Mounjaro for weight loss purposes, citing potential health risks despite its promotion on social media and by beauty clinics.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.


